TrialMedicine2017

Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy as second-line therapy of cytotoxic anticancer drugs in patients with advanced non-small cell lung cancer.

Masaki Anzai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.